TÜBINGEN, Germany / BOSTON, USA – March 16, 2020

CureVac AG announced today that Ingmar Hoerr, CEO of the company, will take a temporary leave of absence for medical reasons. Ingmar Hoerr’s leave is not caused by coronavirus. CureVac’s Supervisory Board fully supports the experienced management team in place and appoints Franz-Werner Haas, Deputy CEO to assume Hoerr’s role until his return.